{'fraction_non_alphanumeric': 0.01807802093244529, 'fraction_numerical': 0.0009514747859181732, 'mean_word_length': 5.045977011494253, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Autologous platelet-rich plasma combined with hyaluronic acid is a new method of minimally invasive treatment of stress urinary incontinence in women

Stress urinary incontinence (SUI) is a common disease. It is 2 times more common among women than in men. The causes of SUI are the insufficiency of the closing function of the sphincter of the bladder and/or hypermobility of the urethra. For this reason, methods aimed at improving the closing function of the urethra, i.e., the use of volume-forming agents are justified for the treatment of this disease. Side effects and time-limited relief of symptoms of urinary incontinence after the application of volumeforming agents, or at the other hand complications after surgery lead to the search for alternative treatments that can restore the natural physiological mechanism of urinary retention. This study demonstrates that administration of platelet-rich autologous plasma in combination with hyaluronic acid in the periurethral region is a safe and effective method of treatment of SUI in women.